4//SEC Filing
GENOCEA BIOSCIENCES, INC. 4
Accession 0001604689-17-000004
CIK 0001457612operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:44 PM ET
Size
9.8 KB
Accession
0001604689-17-000004
Insider Transaction Report
Form 4
Poole Jonathan
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-05-08$6.51/sh−6,213$40,447→ 42,747 total - Award
Common Stock
2017-05-03+23,810→ 48,960 total - Tax Payment
Common Stock
2017-05-10$6.13/sh−3,500$21,455→ 39,247 total - Award
Common Stock
2017-05-03+7,937→ 25,150 total
Footnotes (4)
- [F1]The restricted stock units ("RSUs") were granted in accordance with Genocea Biosciences, Inc.'s (the "Company") 2014 Equity Incentive Plan (the "Plan") and vested immediately upon grant.
- [F2]The RSUs were granted in accordance with the Plan and will vest in full 18 months from the grant date, subject to Mr. Poole's continued employment with the Company.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]Shares sold to cover taxes on RSUs that vested on May 3, 2017.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001457612
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 4:44 PM ET
- Size
- 9.8 KB